Global High Potency Active Pharmaceutical Ingredient Market Professional Survey Report 2016
- QYR740780
- 100 Pages
- October 2016
- Pharmaceuticals
Production, means the output of High Potency Active Pharmaceutical Ingredient
Revenue, means the sales value of High Potency Active Pharmaceutical Ingredient
This report studies High Potency Active Pharmaceutical Ingredient in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Alkermes
Cambex
Dr. Reddy’s Labotatories
Lonza Group
Novasep
Sandoz
...
By types, the market can be split into
Synthetic
Biotech
Type III
By Application, the market can be split into
Oncology
Hormonal disorders
Glaucoma
Others
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
Global High Potency Active Pharmaceutical Ingredient Market Professional Survey Report 2016
1 Industry Overview of High Potency Active Pharmaceutical Ingredient
1.1 Definition and Specifications of High Potency Active Pharmaceutical Ingredient
1.1.1 Definition of High Potency Active Pharmaceutical Ingredient
1.1.2 Specifications of High Potency Active Pharmaceutical Ingredient
1.2 Classification of High Potency Active Pharmaceutical Ingredient
1.2.1 Synthetic
1.2.2 Biotech
1.2.3 Type III
1.3 Applications of High Potency Active Pharmaceutical Ingredient
1.3.1 Oncology
1.3.2 Hormonal disorders
1.3.3 Glaucoma
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of High Potency Active Pharmaceutical Ingredient
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of High Potency Active Pharmaceutical Ingredient
2.3 Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient
2.4 Industry Chain Structure of High Potency Active Pharmaceutical Ingredient
3 Technical Data and Manufacturing Plants Analysis of High Potency Active Pharmaceutical Ingredient
3.1 Capacity and Commercial Production Date of Global High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
4 Global High Potency Active Pharmaceutical Ingredient Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016E Global High Potency Active Pharmaceutical Ingredient Capacity and Growth Rate Analysis
4.2.2 2015 High Potency Active Pharmaceutical Ingredient Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016E Global High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Analysis
4.3.2 2015 High Potency Active Pharmaceutical Ingredient Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016E Global High Potency Active Pharmaceutical Ingredient Sales Price
4.4.2 2015 High Potency Active Pharmaceutical Ingredient Sales Price Analysis (Company Segment)
5 High Potency Active Pharmaceutical Ingredient Regional Market Analysis
5.1 North America High Potency Active Pharmaceutical Ingredient Market Analysis
5.1.1 North America High Potency Active Pharmaceutical Ingredient Market Overview
5.1.2 North America 2011-2016E High Potency Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price Analysis
5.1.4 North America 2015 High Potency Active Pharmaceutical Ingredient Market Share Analysis
5.2 China High Potency Active Pharmaceutical Ingredient Market Analysis
5.2.1 China High Potency Active Pharmaceutical Ingredient Market Overview
5.2.2 China 2011-2016E High Potency Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price Analysis
5.2.4 China 2015 High Potency Active Pharmaceutical Ingredient Market Share Analysis
5.3 Europe High Potency Active Pharmaceutical Ingredient Market Analysis
5.3.1 Europe High Potency Active Pharmaceutical Ingredient Market Overview
5.3.2 Europe 2011-2016E High Potency Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price Analysis
5.3.4 Europe 2015 High Potency Active Pharmaceutical Ingredient Market Share Analysis
5.4 Southeast Asia High Potency Active Pharmaceutical Ingredient Market Analysis
5.4.1 Southeast Asia High Potency Active Pharmaceutical Ingredient Market Overview
5.4.2 Southeast Asia 2011-2016E High Potency Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price Analysis
5.4.4 Southeast Asia 2015 High Potency Active Pharmaceutical Ingredient Market Share Analysis
5.5 Japan High Potency Active Pharmaceutical Ingredient Market Analysis
5.5.1 Japan High Potency Active Pharmaceutical Ingredient Market Overview
5.5.2 Japan 2011-2016E High Potency Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price Analysis
5.5.4 Japan 2015 High Potency Active Pharmaceutical Ingredient Market Share Analysis
5.6 India High Potency Active Pharmaceutical Ingredient Market Analysis
5.6.1 India High Potency Active Pharmaceutical Ingredient Market Overview
5.6.2 India 2011-2016E High Potency Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price Analysis
5.6.4 India 2015 High Potency Active Pharmaceutical Ingredient Market Share Analysis
6 Global 2011-2016E High Potency Active Pharmaceutical Ingredient Segment Market Analysis (by Type)
6.1 Global 2011-2016E High Potency Active Pharmaceutical Ingredient Sales by Type
6.2 Different Types of High Potency Active Pharmaceutical Ingredient Product Interview Price Analysis
6.3 Different Types of High Potency Active Pharmaceutical Ingredient Product Driving Factors Analysis
6.3.1 Synthetic of High Potency Active Pharmaceutical Ingredient Growth Driving Factor Analysis
6.3.2 Biotech of High Potency Active Pharmaceutical Ingredient Growth Driving Factor Analysis
6.3.3 Type III High Potency Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7 Global 2011-2016E High Potency Active Pharmaceutical Ingredient Segment Market Analysis (by Application)
7.1 Global 2011-2016E High Potency Active Pharmaceutical Ingredient Consumption by Application
7.2 Different Application of High Potency Active Pharmaceutical Ingredient Product Interview Price Analysis
7.3 Different Application of High Potency Active Pharmaceutical Ingredient Product Driving Factors Analysis
7.3.1 Oncology of High Potency Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7.3.2 Hormonal disorders of High Potency Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7.3.3 Glaucoma of High Potency Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7.3.4 Others of High Potency Active Pharmaceutical Ingredient Growth Driving Factor Analysis
8 Major Manufacturers Analysis of High Potency Active Pharmaceutical Ingredient
8.1 Alkermes
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Alkermes 2015 High Potency Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Alkermes 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.2 Cambex
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Cambex 2015 High Potency Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Cambex 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.3 Dr. Reddy’s Labotatories
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Dr. Reddy’s Labotatories 2015 High Potency Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Dr. Reddy’s Labotatories 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.4 Lonza Group
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Lonza Group 2015 High Potency Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Lonza Group 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.5 Novasep
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Novasep 2015 High Potency Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Novasep 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.6 Sandoz
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Sandoz 2015 High Potency Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Sandoz 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution Analysis
9 Development Trend of Analysis of High Potency Active Pharmaceutical Ingredient Market
9.1 Global High Potency Active Pharmaceutical Ingredient Market Trend Analysis
9.1.1 Global 2016-2021 High Potency Active Pharmaceutical Ingredient Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 High Potency Active Pharmaceutical Ingredient Sales Price Forecast
9.2 High Potency Active Pharmaceutical Ingredient Regional Market Trend
9.2.1 North America 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Forecast
9.2.2 China 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Forecast
9.2.3 Europe 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Forecast
9.2.4 Southeast Asia 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Forecast
9.2.5 Japan 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Forecast
9.2.6 India 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Forecast
9.3 High Potency Active Pharmaceutical Ingredient Market Trend (Product Type)
9.4 High Potency Active Pharmaceutical Ingredient Market Trend (Application)
10 High Potency Active Pharmaceutical Ingredient Marketing Type Analysis
10.1 High Potency Active Pharmaceutical Ingredient Regional Marketing Type Analysis
10.2 High Potency Active Pharmaceutical Ingredient International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of High Potency Active Pharmaceutical Ingredient by Regions
10.4 High Potency Active Pharmaceutical Ingredient Supply Chain Analysis
11 Consumers Analysis of High Potency Active Pharmaceutical Ingredient
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global High Potency Active Pharmaceutical Ingredient Market Professional Survey Report 2016
Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of High Potency Active Pharmaceutical Ingredient
Table Product Specifications of High Potency Active Pharmaceutical Ingredient
Table Classification of High Potency Active Pharmaceutical Ingredient
Figure Global Production Market Share of High Potency Active Pharmaceutical Ingredient by Type in 2015
Figure Synthetic Picture
Table Major Manufacturers of Synthetic
Figure Biotech Picture
Table Major Manufacturers of Biotech
Table Applications of High Potency Active Pharmaceutical Ingredient
Figure Global Consumption Volume Market Share of High Potency Active Pharmaceutical Ingredient by Application in 2015
Figure Oncology Examples
Table Major Consumers of Oncology
Figure Hormonal disorders Examples
Table Major Consumers of Hormonal disorders
Figure Glaucoma Examples
Table Major Consumers of Glaucoma
Figure Others Examples
Table Major Consumers of Others
Figure Market Share of High Potency Active Pharmaceutical Ingredient by Regions
Figure North America High Potency Active Pharmaceutical Ingredient Market Size (2011-2021)
Figure China High Potency Active Pharmaceutical Ingredient Market Size (2011-2021)
Figure Europe High Potency Active Pharmaceutical Ingredient Market Size (2011-2021)
Figure Southeast Asia High Potency Active Pharmaceutical Ingredient Market Size (2011-2021)
Figure Japan High Potency Active Pharmaceutical Ingredient Market Size (2011-2021)
Figure India High Potency Active Pharmaceutical Ingredient Market Size (2011-2021)
Table High Potency Active Pharmaceutical Ingredient Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of High Potency Active Pharmaceutical Ingredient in 2015
Figure Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient
Figure Industry Chain Structure of High Potency Active Pharmaceutical Ingredient
Table Capacity (K T) and Commercial Production Date of Global High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
Table R&D Status and Technology Source of Global High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
Table Global Capacity (K T) , Sales (K T) , Price (USD/T) , Cost (USD/T) , Sales Revenue (M USD) and Gross Margin of High Potency Active Pharmaceutical Ingredient 2011-2016
Figure Global 2011-2016E High Potency Active Pharmaceutical Ingredient Market Size (Volume) and Growth Rate
Figure Global 2011-2016E High Potency Active Pharmaceutical Ingredient Market Size (Value) and Growth Rate
Table 2011-2016E Global High Potency Active Pharmaceutical Ingredient Capacity and Growth Rate
Table 2015 Global High Potency Active Pharmaceutical Ingredient Capacity List (Company Segment)
Table 2011-2016E Global High Potency Active Pharmaceutical Ingredient Sales and Growth Rate
Table 2015 Global High Potency Active Pharmaceutical Ingredient Sales List (Company Segment)
Table 2011-2016E Global High Potency Active Pharmaceutical Ingredient Sales Price
Table 2015 Global High Potency Active Pharmaceutical Ingredient Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of High Potency Active Pharmaceutical Ingredient 2011-2016 (K T)
Figure North America 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price (USD/T)
Figure North America 2015 High Potency Active Pharmaceutical Ingredient Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of High Potency Active Pharmaceutical Ingredient 2011-2016 (K T)
Figure China 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price (USD/T)
Figure China 2015 High Potency Active Pharmaceutical Ingredient Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of High Potency Active Pharmaceutical Ingredient 2011-2016 (K T)
Figure Europe 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price (USD/T)
Figure Europe 2015 High Potency Active Pharmaceutical Ingredient Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of High Potency Active Pharmaceutical Ingredient 2011-2016 (K T)
Figure Southeast Asia 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price (USD/T)
Figure Southeast Asia 2015 High Potency Active Pharmaceutical Ingredient Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of High Potency Active Pharmaceutical Ingredient 2011-2016 (K T)
Figure Japan 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price (USD/T)
Figure Japan 2015 High Potency Active Pharmaceutical Ingredient Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of High Potency Active Pharmaceutical Ingredient 2011-2016 (K T)
Figure India 2011-2016E High Potency Active Pharmaceutical Ingredient Sales Price (USD/T)
Figure India 2015 High Potency Active Pharmaceutical Ingredient Sales Market Share
Table Global 2011-2016E High Potency Active Pharmaceutical Ingredient Sales by Type
Table Different Types High Potency Active Pharmaceutical Ingredient Product Interview Price
Table Global 2011-2016E High Potency Active Pharmaceutical Ingredient Sales by Application
Table Different Application High Potency Active Pharmaceutical Ingredient Product Interview Price
Table Alkermes Information List
Table Type I High Potency Active Pharmaceutical Ingredient Overview
Table Type II High Potency Active Pharmaceutical Ingredient Overview
Table Type III High Potency Active Pharmaceutical Ingredient Overview
Table 2015 Alkermes High Potency Active Pharmaceutical Ingredient Revenue, Sales, Ex-factory Price
Figure 2015 Alkermes 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution
Table Cambex Information List
Table Type I High Potency Active Pharmaceutical Ingredient Overview
Table Type II High Potency Active Pharmaceutical Ingredient Overview
Table Type III High Potency Active Pharmaceutical Ingredient Overview
Table 2015 Cambex High Potency Active Pharmaceutical Ingredient Revenue, Sales, Ex-factory Price
Figure 2015 Cambex 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution
Table Dr. Reddy’s Labotatories Information List
Table Type I High Potency Active Pharmaceutical Ingredient Overview
Table Type II High Potency Active Pharmaceutical Ingredient Overview
Table Type III High Potency Active Pharmaceutical Ingredient Overview
Table 2015 Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Revenue, Sales, Ex-factory Price
Figure 2015 Dr. Reddy’s Labotatories 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution
Table Lonza Group Information List
Table Type I High Potency Active Pharmaceutical Ingredient Overview
Table Type II High Potency Active Pharmaceutical Ingredient Overview
Table Type III High Potency Active Pharmaceutical Ingredient Overview
Table 2015 Lonza Group High Potency Active Pharmaceutical Ingredient Revenue, Sales, Ex-factory Price
Figure 2015 Lonza Group 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution
Table Novasep Information List
Table Type I High Potency Active Pharmaceutical Ingredient Overview
Table Type II High Potency Active Pharmaceutical Ingredient Overview
Table Type III High Potency Active Pharmaceutical Ingredient Overview
Table 2015 Novasep High Potency Active Pharmaceutical Ingredient Revenue, Sales, Ex-factory Price
Figure 2015 Novasep 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution
Table Sandoz Information List
Table Type I High Potency Active Pharmaceutical Ingredient Overview
Table Type II High Potency Active Pharmaceutical Ingredient Overview
Table Type III High Potency Active Pharmaceutical Ingredient Overview
Table 2015 Sandoz High Potency Active Pharmaceutical Ingredient Revenue, Sales, Ex-factory Price
Figure 2015 Sandoz 2015 High Potency Active Pharmaceutical Ingredient Business Region Distribution
Figure Global 2016-2021 High Potency Active Pharmaceutical Ingredient Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 High Potency Active Pharmaceutical Ingredient Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 High Potency Active Pharmaceutical Ingredient Sales Price (USD/T) Forecast
Figure North America 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 High Potency Active Pharmaceutical Ingredient Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K T) of High Potency Active Pharmaceutical Ingredient by Types 2016-2021
Table Global Consumption Volume (K T) of High Potency Active Pharmaceutical Ingredient by Applications 2016-2021
Table Traders or Distributors with Contact Information of High Potency Active Pharmaceutical Ingredient by Regions
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
